Cargando…

Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data

BACKGROUND: There is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the development of effective management strategies for these infections. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Verheij, Theo J, Cianci, Daniela, van der Velden, Alike W, Butler, Christopher C, Bongard, Emily, Coenen, Samuel, Colliers, Annelies, Francis, Nick A, Little, Paul, Godycki-Cwirko, Maciek, Llor, Carl, Chlabicz, Sławomir, Lionis, Christos, Sundvall, Pär-Daniel, Bjerrum, Lars, De Sutter, An, Aabenhus, Rune, Harbin, Nicolay Jonassen, Lindbæk, Morten, Glinz, Dominik, Bucher, Heiner C, Kovács, Bernadett, Seifert, Bohumil, Jurgute, Ruta Radzeviciene, Lundgren, Pia Touboul, de Paor, Muireann, Matheeussen, Veerle, Goossens, Herman, Ieven, Margareta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803087/
https://www.ncbi.nlm.nih.gov/pubmed/34990385
http://dx.doi.org/10.3399/BJGP.2021.0344
_version_ 1784642794963337216
author Verheij, Theo J
Cianci, Daniela
van der Velden, Alike W
Butler, Christopher C
Bongard, Emily
Coenen, Samuel
Colliers, Annelies
Francis, Nick A
Little, Paul
Godycki-Cwirko, Maciek
Llor, Carl
Chlabicz, Sławomir
Lionis, Christos
Sundvall, Pär-Daniel
Bjerrum, Lars
De Sutter, An
Aabenhus, Rune
Harbin, Nicolay Jonassen
Lindbæk, Morten
Glinz, Dominik
Bucher, Heiner C
Kovács, Bernadett
Seifert, Bohumil
Jurgute, Ruta Radzeviciene
Lundgren, Pia Touboul
de Paor, Muireann
Matheeussen, Veerle
Goossens, Herman
Ieven, Margareta
author_facet Verheij, Theo J
Cianci, Daniela
van der Velden, Alike W
Butler, Christopher C
Bongard, Emily
Coenen, Samuel
Colliers, Annelies
Francis, Nick A
Little, Paul
Godycki-Cwirko, Maciek
Llor, Carl
Chlabicz, Sławomir
Lionis, Christos
Sundvall, Pär-Daniel
Bjerrum, Lars
De Sutter, An
Aabenhus, Rune
Harbin, Nicolay Jonassen
Lindbæk, Morten
Glinz, Dominik
Bucher, Heiner C
Kovács, Bernadett
Seifert, Bohumil
Jurgute, Ruta Radzeviciene
Lundgren, Pia Touboul
de Paor, Muireann
Matheeussen, Veerle
Goossens, Herman
Ieven, Margareta
author_sort Verheij, Theo J
collection PubMed
description BACKGROUND: There is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the development of effective management strategies for these infections. AIM: To investigate whether clinical presentation and illness course differ between RTIs where a viral pathogen was detected and those where a potential bacterial pathogen was found. DESIGN AND SETTING: Post hoc analysis of data from a pragmatic randomised trial on the effects of oseltamivir in patients with flu-like illness in primary care (n = 3266) in 15 European countries. METHOD: Patient characteristics and their signs and symptoms of disease were registered at baseline. Nasopharyngeal (adults) or nasal and pharyngeal (children) swabs were taken for polymerase chain reaction analysis. Patients were followed up until 28 days after inclusion. Regression models and Kaplan–Meier curves were used to analyse the relationship between aetiology, clinical presentation at baseline, and course of disease including complications. RESULTS: Except for a less prominent congested nose (odds ratio [OR] 0.55, 95% confidence interval [CI] = 0.35 to 0.86) and acute cough (OR 0.42, 95% CI = 0.27 to 0.65) in patients with flu-like illness in whom a possible bacterial pathogen was isolated, there were no clear clinical differences in presentations between those with a possible bacterial aetiology compared with those with a viral aetiology. Also, course of disease and complications were not related to aetiology. CONCLUSION: Given current available microbiological tests and antimicrobial treatments, and outside pandemics such as COVID-19, microbiological testing in primary care patients with flu-like illness seems to have limited value. A wait-and-see policy in most of these patients with flu-like illness seems the best option.
format Online
Article
Text
id pubmed-8803087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-88030872022-02-23 Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data Verheij, Theo J Cianci, Daniela van der Velden, Alike W Butler, Christopher C Bongard, Emily Coenen, Samuel Colliers, Annelies Francis, Nick A Little, Paul Godycki-Cwirko, Maciek Llor, Carl Chlabicz, Sławomir Lionis, Christos Sundvall, Pär-Daniel Bjerrum, Lars De Sutter, An Aabenhus, Rune Harbin, Nicolay Jonassen Lindbæk, Morten Glinz, Dominik Bucher, Heiner C Kovács, Bernadett Seifert, Bohumil Jurgute, Ruta Radzeviciene Lundgren, Pia Touboul de Paor, Muireann Matheeussen, Veerle Goossens, Herman Ieven, Margareta Br J Gen Pract Research BACKGROUND: There is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the development of effective management strategies for these infections. AIM: To investigate whether clinical presentation and illness course differ between RTIs where a viral pathogen was detected and those where a potential bacterial pathogen was found. DESIGN AND SETTING: Post hoc analysis of data from a pragmatic randomised trial on the effects of oseltamivir in patients with flu-like illness in primary care (n = 3266) in 15 European countries. METHOD: Patient characteristics and their signs and symptoms of disease were registered at baseline. Nasopharyngeal (adults) or nasal and pharyngeal (children) swabs were taken for polymerase chain reaction analysis. Patients were followed up until 28 days after inclusion. Regression models and Kaplan–Meier curves were used to analyse the relationship between aetiology, clinical presentation at baseline, and course of disease including complications. RESULTS: Except for a less prominent congested nose (odds ratio [OR] 0.55, 95% confidence interval [CI] = 0.35 to 0.86) and acute cough (OR 0.42, 95% CI = 0.27 to 0.65) in patients with flu-like illness in whom a possible bacterial pathogen was isolated, there were no clear clinical differences in presentations between those with a possible bacterial aetiology compared with those with a viral aetiology. Also, course of disease and complications were not related to aetiology. CONCLUSION: Given current available microbiological tests and antimicrobial treatments, and outside pandemics such as COVID-19, microbiological testing in primary care patients with flu-like illness seems to have limited value. A wait-and-see policy in most of these patients with flu-like illness seems the best option. Royal College of General Practitioners 2022-01-25 /pmc/articles/PMC8803087/ /pubmed/34990385 http://dx.doi.org/10.3399/BJGP.2021.0344 Text en © The Authors https://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Research
Verheij, Theo J
Cianci, Daniela
van der Velden, Alike W
Butler, Christopher C
Bongard, Emily
Coenen, Samuel
Colliers, Annelies
Francis, Nick A
Little, Paul
Godycki-Cwirko, Maciek
Llor, Carl
Chlabicz, Sławomir
Lionis, Christos
Sundvall, Pär-Daniel
Bjerrum, Lars
De Sutter, An
Aabenhus, Rune
Harbin, Nicolay Jonassen
Lindbæk, Morten
Glinz, Dominik
Bucher, Heiner C
Kovács, Bernadett
Seifert, Bohumil
Jurgute, Ruta Radzeviciene
Lundgren, Pia Touboul
de Paor, Muireann
Matheeussen, Veerle
Goossens, Herman
Ieven, Margareta
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
title Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
title_full Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
title_fullStr Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
title_full_unstemmed Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
title_short Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
title_sort clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803087/
https://www.ncbi.nlm.nih.gov/pubmed/34990385
http://dx.doi.org/10.3399/BJGP.2021.0344
work_keys_str_mv AT verheijtheoj clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT ciancidaniela clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT vanderveldenalikew clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT butlerchristopherc clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT bongardemily clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT coenensamuel clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT colliersannelies clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT francisnicka clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT littlepaul clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT godyckicwirkomaciek clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT llorcarl clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT chlabiczsławomir clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT lionischristos clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT sundvallpardaniel clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT bjerrumlars clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT desutteran clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT aabenhusrune clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT harbinnicolayjonassen clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT lindbækmorten clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT glinzdominik clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT bucherheinerc clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT kovacsbernadett clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT seifertbohumil clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT jurguterutaradzeviciene clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT lundgrenpiatouboul clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT depaormuireann clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT matheeussenveerle clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT goossensherman clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata
AT ievenmargareta clinicalpresentationmicrobiologicalaetiologyanddiseasecourseinpatientswithflulikeillnessaposthocanalysisofrandomisedcontrolledtrialdata